NDC 61958-2505

Biktarvy

Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate

Biktarvy is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Bictegravir Sodium; Emtricitabine; Tenofovir Alafenamide Fumarate.

• Product ID: 61958-2505_12754803-c0a0-4971-8c17-8348aab6a417
• NDC: 61958-2505
• Product Type: Human Prescription Drug
• Proprietary Name: Biktarvy
• Generic Name: Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2021-10-07
• Marketing Category: NDA /
• Application Number: NDA210251
• Labeler Name: Gilead Sciences, Inc.
• Substance Name: BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
• Active Ingredient Strength: 30 mg/1; mg/1; mg/1
• Pharm Classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 61958-2505-1

30 TABLET in 1 BOTTLE, PLASTIC (61958-2505-1)

• Marketing Start Date: 2021-10-07
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Biktarvy" or generic name "Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate"

NDC	Brand Name	Generic Name
50090-6247	Biktarvy	bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
61958-2501	Biktarvy	bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
61958-2505	Biktarvy	bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
70518-3080	Biktarvy	bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate